22 Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Osiris Therapeutics, Inc. OSIR shares rose 15 percent to $4.82 in pre-market trading. Osiris Therapeutics expects that 2014 will restate revenue to $46 million-$50 million. The company projects 2015 revenue of $85 million to $90 million and FY16 revenue of$100 million to $110 million.
• ACADIA Pharmaceuticals Inc. ACAD shares rose 11.4 percent to $25.60 in pre-market trading. Acadia Pharmaceuticals reported a Q3 loss of $71.6 million on revenue of $5.3 million.
• Momo Inc (ADR) MOMO rose 10.4 percent to $29.50 in pre-market trading following strong Q3 earnings report and guidance.
• Pernix Therapeutics Holdings Inc PTX shares rose 8.1 percent to $4.16 in pre-market trading. Pernix Therapeutics reported the appointment of Graham G. Miao, Ph.D. and Dennis H. Langer, M.D., J.D. to its board.
• Avino Silver and Gold Mines Ltd ASM rose 7.8 percent to $2.50 in pre-market trading. Avino Silver and Gold Mines is expected to release Q3 results today.
• IAMGOLD Corp (USA) IAG rose 5.8 percent to $4.20 in the pre-market trading session after reporting better-than-expected Q3 earnings.
• Johnson Controls International plc JCI shares rose 5.7 percent to $43.95 in pre-market trading as the company reported better-than-expected Q4 results.
• Endo International plc ENDP rose 5.9 percent to $16.60 in pre-market trading after the company posted upbeat quarterly results.
• Priceline Group Inc PCLN rose 4.8 percent to $1,551.00 in pre-market trading after the company reported stronger-than-expected earnings for its third quarter. The firm’s interim CEO, Brett Keller, has been named Chief Executive Officer of Priceline.com, and will respond to the company’s Interim CEO and Chairman of the Board Jeffery H. Boyd.
• Omeros Corporation OMER rose 4.8 percent to $10.30 in pre-market trading. Omeros Corporation is expected to announce Q3 financial results on November 9, 2016.
• Wayfair Inc W rose 3.7 percent to $34.90 in pre-market trading after the company posted upbeat Q3 results.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Hertz Global Holdings, Inc HTZ shares fell 36.3 percent to $22.76 in pre-market trading after the company reported weaker-than-expected results for the third quarter and provided downbeat forecast for the full year.
• OneMain Holdings Inc OMF fell 35.1 percent to $17.90 in pre-market trading on weak Q3 earnings. Several analysts downgraded the stock following results.
• Rockwell Medical Inc RMTI shares fell 27.9 percent to $4.08 in pre-market trading. Rockwell Medical reported a Q3 loss of $0.09 per share on revenue of $12.8 million.
• Kindred Healthcare, Inc. KND shares fell 25.1 percent to $6.55 in pre-market trading after the company reported wider Q3 loss and announced plans to exit the skilled nursing facility business.
• CGG SA (ADR) CGG shares fell 23.6 percent to $19.80 in pre-market trading. CGG posted a Q3 loss of $3.95 per share on revenue of $264 million.
• CVS Health Corp CVS shares fell 15 percent to $70.96 in pre-market trading. CVS delivered better than expected EPS for the third quarter though revenue missed. However, the company offered downbeat guidance for the fourth quarter and next year.
• Depomed Inc DEPO shares fell 12 percent to $20.15 in pre-market trading following Q3 results. Depomed reported a Q3 loss of $0.21 per share on revenue of $110.524 million.
• Nevro Corp NVRO shares fell 9.7 percent to $80.50 in the pre-market trading session. Nevro reported a Q3 loss of $0.14 per share on revenue of $60.9 million. The company also raised its FY16 revenue guidance.
• Valeant Pharmaceuticals Intl Inc VRX fell 9.3 percent to $17.36 in pre-market trading as the company reported weaker-than-expected earnings for its third quarter and lowered its full year fiscal 2016 guidance.
• Gravity Co., LTD. (ADR) GRVY fell 7.8 percent to $13.75 in pre-market trading after gaining 13.09 percent on Monday.
• D.R. Horton, Inc. DHI fell 5.5 percent to $ 27.75 in pre-market trading after the company reported downbeat earnings for the fourth quarter.